Gene: PDS5B
Official Full Name: PDS5 cohesin associated factor Bprovided by HGNC
Gene Summary: This gene encodes a protein that interacts with the conserved protein complex termed cohesin. The cohesin complex holds together sister chromatids and facilitates accurate chromosome segregation during mitosis and meiosis. This protein is also a negative regulator of cell proliferation and may be a tumor-suppressor gene. [provided by RefSeq, Jul 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29975 | PDS5B Knockout cell line (HeLa) | Human | PDS5B | 1:3~1:6 | Negative | Online Inquiry |
KO29976 | PDS5B Knockout cell line (HCT 116) | Human | PDS5B | 1:2~1:4 | Negative | Online Inquiry |
KO29977 | PDS5B Knockout cell line (HEK293) | Human | PDS5B | 1:3~1:6 | Negative | Online Inquiry |
KO29978 | PDS5B Knockout cell line (A549) | Human | PDS5B | 1:3~1:4 | Negative | Online Inquiry |
PDS5B Gene Knockout Cell Lines represent a revolutionary advancement in genetic research, designed specifically for in-depth studies of gene function and regulation. PDS5B, an important regulator in the cohesion complex during the cell cycle, plays a critical role in chromosome stability. By utilizing a CRISPR-Cas9 gene-editing approach, these cell lines exhibit a complete knockout of the PDS5B gene, allowing researchers to observe the resultant phenotypic changes and dissect the molecular pathways influenced by its absence.
The primary mechanism of action involves the precise alteration of the genome to create deletions in the PDS5B gene, which subsequently allows for an insightful examination of how the gene’s inactivation affects processes such as DNA repair, chromosomal segregation, and cell proliferation. This knockout model is pivotal for understanding the pathophysiology associated with aberrations in chromosome behavior, which can lead to an array of diseases, including cancer.
In both research and clinical settings, PDS5B Gene Knockout Cell Lines serve as an indispensable tool, advancing our knowledge of genetic disorders, cell cycle progression, and potential therapeutic targets. Their unique ability to eliminate confounding genetic variables helps streamline experimental outcomes, making them preferable over traditional methods that may not yield the same specificity or reliability.
Compared to existing gene knockout technologies, these cell lines offer enhanced targeting precision, a validated performance track record, and compatibility with various assay types. Furthermore, the availability of robust characterizations provides researchers with confidence in their experimental designs, ultimately accelerating discovery timelines.
For researchers and clinicians focused on the genetic underpinnings of human disease, PDS5B Gene Knockout Cell Lines are uniquely positioned to deliver critical insights. With a commitment to innovation and scientific excellence, our company's expertise in developing high-quality biological products ensures that we meet and exceed the needs of the research community, enabling groundbreaking discoveries in genomic science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.